X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2776) 2776
Publication (216) 216
Newsletter (200) 200
Book Review (31) 31
Newspaper Article (22) 22
Magazine Article (11) 11
Book Chapter (4) 4
Dissertation (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
paroxetine (2037) 2037
humans (1740) 1740
male (1476) 1476
female (1172) 1172
psychiatry (1049) 1049
adult (933) 933
pharmacology & pharmacy (895) 895
index medicus (804) 804
middle aged (732) 732
antidepressants (610) 610
neurosciences (590) 590
animals (579) 579
paroxetine - therapeutic use (556) 556
fluoxetine (526) 526
treatment outcome (525) 525
paroxetine - administration & dosage (520) 520
serotonin uptake inhibitors - therapeutic use (511) 511
depression (489) 489
serotonin (438) 438
paroxetine - adverse effects (430) 430
serotonin uptake inhibitors - administration & dosage (427) 427
paroxetine - pharmacology (400) 400
double-blind (399) 399
serotonin uptake inhibitors - adverse effects (395) 395
aged (390) 390
dose-response relationship, drug (384) 384
rats (377) 377
double-blind method (373) 373
drug therapy (351) 351
serotonin uptake inhibitors - pharmacology (339) 339
drug administration schedule (327) 327
depressive disorder - drug therapy (308) 308
dosage and administration (308) 308
sertraline (301) 301
clinical neurology (297) 297
research (297) 297
depressive disorder, major - drug therapy (283) 283
major depression (279) 279
adolescent (276) 276
serotonin reuptake inhibitors (272) 272
antidepressive agents - therapeutic use (246) 246
efficacy (237) 237
depression, mental (233) 233
major depressive disorder (226) 226
serotonin uptake inhibitors (225) 225
psychiatric status rating scales (215) 215
time factors (214) 214
antidepressive agents, second-generation - therapeutic use (209) 209
anxiety (205) 205
care and treatment (195) 195
citalopram (194) 194
antidepressive agents, second-generation - administration & dosage (193) 193
drug therapy, combination (189) 189
placebo (189) 189
analysis (186) 186
antidepressive agents, second-generation - adverse effects (183) 183
drugs (183) 183
drug interactions (180) 180
antidepressant (175) 175
serotonin - metabolism (175) 175
depression - drug therapy (174) 174
antidepressive agents - administration & dosage (173) 173
risk factors (171) 171
health aspects (170) 170
mice (168) 168
rats, sprague-dawley (168) 168
fluvoxamine (166) 166
psychology, clinical (162) 162
brain (154) 154
complications and side effects (154) 154
venlafaxine (152) 152
antidepressive agents - pharmacology (150) 150
antidepressive agents - adverse effects (147) 147
medicine, general & internal (146) 146
brain - metabolism (136) 136
clinical trials (136) 136
young adult (136) 136
mental depression (135) 135
venlafaxine hydrochloride (130) 130
pharmacokinetics (125) 125
severity of illness index (125) 125
ssri (122) 122
placebo-controlled trial (121) 121
brain - drug effects (119) 119
depressive disorder - psychology (116) 116
pharmacology (111) 111
imipramine (110) 110
fluoxetine - therapeutic use (107) 107
medicine & public health (105) 105
obsessive-compulsive disorder (102) 102
pharmacotherapy (101) 101
child (100) 100
pharmacology/toxicology (100) 100
paroxetine - pharmacokinetics (99) 99
psychology (98) 98
risk (98) 98
citalopram - therapeutic use (95) 95
follow-up studies (95) 95
disorder (94) 94
selective serotonin reuptake inhibitors (94) 94
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2929) 2929
French (16) 16
German (12) 12
Dutch (9) 9
Japanese (9) 9
Russian (9) 9
Spanish (7) 7
Chinese (4) 4
Norwegian (4) 4
Polish (4) 4
Italian (3) 3
Swedish (2) 2
Catalan (1) 1
Danish (1) 1
Korean (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 881 - 890
Summary Background Major depressive disorder is one of the most common mental disorders in children and adolescents. However, whether to use pharmacological... 
Internal Medicine | TRIALS | MEDICINE, GENERAL & INTERNAL | ACCEPTABILITY | MENTAL-HEALTH-CARE | TRENDS | GUIDELINES | Mianserin - adverse effects | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Citalopram - adverse effects | Sertraline - adverse effects | Venlafaxine Hydrochloride - adverse effects | Imipramine - administration & dosage | Paroxetine - adverse effects | Mianserin - analogs & derivatives | Paroxetine - administration & dosage | Desipramine - adverse effects | Nortriptyline - administration & dosage | Nortriptyline - adverse effects | Mianserin - administration & dosage | Child | Fluoxetine - adverse effects | Depressive Disorder, Major - drug therapy | Clomipramine - administration & dosage | Duloxetine Hydrochloride - adverse effects | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Clomipramine - adverse effects | Evidence-Based Medicine | Desipramine - administration & dosage | Randomized Controlled Trials as Topic | Venlafaxine Hydrochloride - administration & dosage | Citalopram - administration & dosage | Confounding Factors (Epidemiology) | Sertraline - administration & dosage | Adolescent | Amitriptyline - adverse effects | Bayes Theorem | Fluoxetine - administration & dosage | Duloxetine Hydrochloride - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Research Design | Amitriptyline - administration & dosage | Imipramine - adverse effects | Psychological aspects | Medical colleges | Neurosciences | Drugs and youth | Rankings | Comparative analysis | Child psychopathology | Major depressive disorder | Antidepressants, Tricyclic | Pediatric pharmacology | Mental illness | Studies | Teenagers | Mental depression | Antidepressants | Meta-analysis | Children & youth
Journal Article
Journal Article
CMAJ, ISSN 0820-3946, 11/2011, Volume 183, Issue 16, pp. 1835 - 1843
Background: Patients prescribed antiplatelet treatment to prevent recurrent acute myocardial infarction are often also given a selective serotonin reuptake... 
DEPRESSION | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | ANTIDEPRESSANTS | CLOPIDOGREL | EVENTS | PROGNOSIS | DRUGS | ELDERLY-PATIENTS | ASPIRIN | Age Factors | Anemia - epidemiology | Angioplasty | Humans | Middle Aged | Citalopram - adverse effects | Male | Risk | Secondary Prevention | Sertraline - adverse effects | Peptic Ulcer - epidemiology | Adrenal Cortex Hormones - therapeutic use | Renal Insufficiency - epidemiology | Aspirin - administration & dosage | Paroxetine - adverse effects | Paroxetine - administration & dosage | Fluvoxamine - administration & dosage | Canada - epidemiology | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Retrospective Studies | Drug Therapy, Combination | Heart Failure - epidemiology | Fluoxetine - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Hemorrhage - epidemiology | Risk Factors | Serotonin Uptake Inhibitors - adverse effects | Anticoagulants - therapeutic use | Antihypertensive Agents - therapeutic use | Fluvoxamine - adverse effects | Ticlopidine - analogs & derivatives | Citalopram - administration & dosage | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Sex Factors | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Neoplasms - epidemiology | Cohort Studies | Aggregation | Complications and side effects | Blood platelets | Patient outcomes | Serotonin uptake inhibitors | Dosage and administration | Drug therapy | Hemorrhage | Heart attack | Risk factors | Studies | Side effects | Heart attacks | Inhibitor drugs | Research
Journal Article
Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 16, pp. 1229 - 1236
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2005, Volume 97, Issue 1, pp. 30 - 39
Background: The efficacy of tamoxifen therapy for the treatment of breast cancer varies widely among individuals. Plasma concentrations of the active tamoxifen... 
PERFORMANCE LIQUID-CHROMATOGRAPHY | TRIAL | IN-VITRO | PLASMA | ONCOLOGY | JAPANESE POPULATION | ALLELE FREQUENCY | PAROXETINE | POSTMENOPAUSAL WOMEN | HOT FLASHES | CYTOCHROME-P450 2D6 | Cytochrome P-450 CYP2C9 | Cytochrome P-450 CYP2D6 Inhibitors | Prospective Studies | Cytochrome P-450 CYP3A | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Antidepressive Agents, Second-Generation - administration & dosage | Tamoxifen - administration & dosage | Antineoplastic Agents, Hormonal - metabolism | Breast Neoplasms - metabolism | Breast Neoplasms - enzymology | Cyclohexanols - metabolism | Time Factors | Adult | Female | Chemotherapy, Adjuvant | Serotonin Uptake Inhibitors - metabolism | Tamoxifen - metabolism | Cytochrome P-450 CYP2D6 - genetics | Drug Administration Schedule | Enzyme Inhibitors - metabolism | Estrogen Receptor Modulators - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Tamoxifen - blood | Genotype | Arylsulfotransferase - genetics | Estrogen Receptor Modulators - blood | Breast Neoplasms - drug therapy | Antineoplastic Agents, Hormonal - blood | Venlafaxine Hydrochloride | Serotonin Uptake Inhibitors - administration & dosage | Cytochrome P-450 Enzyme System - genetics | Aged | Estrogen Receptor Modulators - metabolism | Antidepressive Agents, Second-Generation - metabolism | Breast cancer | Dosage and administration | Drug therapy | Tamoxifen | Antidepressants
Journal Article
Journal Article